U.S. Food and Drug Administration Story Archives - West Virginia Public Broadcasting

Mylan Lays Off 15 Percent of West Virginia Workforce

A pharmaceuticals company has laid off 15 percent of its workforce at a West Virginia manufacturing facility.

Mylan Pharmaceuticals released a statement Friday saying the “right-sizing” is consistent with discussions with the U.S. Food and Drug Administration to continue operations. Mylan spokeswoman Christine Waller tells The Dominion Post that around 500 positions have been cut, leaving the West Virginia workforce at around 3,000.

In response to a question that asked if the layoffs were connected to FDA inspections of the plant, Waller said the goal was to reduce the site’s size and complexity.

The layoffs are effective immediately. The company is still in discussion with United Steel Workers Local 8-957 regarding separation packages for senior union members.

Union leaders were in meetings Friday and couldn’t be reached for comment.

Gabapentin Contributes to Spike in Overdose Deaths in W. Va.

A West Virginia Board of Pharmacy report says a prescription drug used to treat nerve pain is contributing to a sharp increase of overdose deaths in the state.

The Charleston Gazette-Mail reports the number of fatal overdoses involving gabapentin in West Virginia jumped from three in 2010 to 109 in 2015. The number of 2016 deaths are still being counted.

Pharmacy board administrator Mike Goff, who oversees the state’s drug-monitoring database, says gabapentin is showing up in cocktails of drugs that are linked to overdose deaths. Users seeking a euphoric high mix the drug with opioids or muscle-relaxants and anti-anxiety medications.

“Sometimes, they have prescriptions for all of them,” Goff said.

The increase in deaths has prompted a pharmacy board committee to recommend making gabapentin a controlled substance in West Virginia, enabling the pharmacy board to track prescriptions for the drug, which is sold by Pfizer under the brand name Neurontin.

Goff says currently the volume of gabapentin prescriptions in the state isn’t known.

The gabapentin-related overdose deaths were cited in the pharmacy board’s annual report released last week.

Gabapentin has been approved by the U.S. Food and Drug Administration to treat seizures and pain caused by shingles. It also is used by some veterinarians to treat epilepsy and seizures in dogs and cats.

The U.S. Centers for Disease Control and Prevention has touted gabapentin as a safer alternative to prescription opioids.

Ohio started requiring pharmacies to report sales of gabapentin on Dec. 1.

West Virginia Gets $253,500 Share of Drug Case Settlement

Attorney General Patrick Morrisey says West Virginia will receive a $253,500 share of a settlement with Bristol-Myers Squibb involving allegations that it promoted the anti-psychotic drug Abilify for unapproved uses.

Morrisey announced the state’s share of the $19.5 million settlement in a news release. Forty-two other states were involved in the legal action.

Abilify is approved by the U.S. Food and Drug Administration to treat schizophrenia, bipolar disorder, major depressive disorder and Tourette’s disorder in adults and children. California alleged that Bristol-Myers Squibb promoted the schizophrenia drug for unapproved uses on children and for elderly patients with dementia.